药物生物技术
藥物生物技術
약물생물기술
PHARMACEUTICAL BIOTECHNOLOGY
2001年
1期
4-7
,共4页
熊盛%林剑%洪岸%刘杰森%张玲%李志英%姚汝华
熊盛%林劍%洪岸%劉傑森%張玲%李誌英%姚汝華
웅성%림검%홍안%류걸삼%장령%리지영%요여화
pET载体%多克隆位点%目视法筛选%牛碱性成纤维细胞生长因 子%表达
pET載體%多剋隆位點%目視法篩選%牛堿性成纖維細胞生長因 子%錶達
pET재체%다극륭위점%목시법사선%우감성성섬유세포생장인 자%표체
pET vector%Multiple cloning sites%Visual screen%BbFGF%Expression
对原核表达载体pET3c进行改建,消去载体上非必需的EcoRⅠ、HindⅢ限制酶位点,然后在克隆位点BamHⅠ处引入LacZ片段,经此二步改建后的载体命名为pJN982。该载体保留了pET3c高效表达外源基因的能力,同时,其融合克隆位点由1个增至7个,并获得以目视法筛选重组子的能力。应用该载体在E.coliBL21(DE3)pLysS中融合表达牛碱性成纤维细胞生长因子,表达量占菌体总蛋白30.04%。破碎菌体上清经阳离子交换和肝素亲和两步层析,得纯度为95%的重组蛋白,活性检测显示,重组蛋白具有与参照品一致的促有丝分裂活性。
對原覈錶達載體pET3c進行改建,消去載體上非必需的EcoRⅠ、HindⅢ限製酶位點,然後在剋隆位點BamHⅠ處引入LacZ片段,經此二步改建後的載體命名為pJN982。該載體保留瞭pET3c高效錶達外源基因的能力,同時,其融閤剋隆位點由1箇增至7箇,併穫得以目視法篩選重組子的能力。應用該載體在E.coliBL21(DE3)pLysS中融閤錶達牛堿性成纖維細胞生長因子,錶達量佔菌體總蛋白30.04%。破碎菌體上清經暘離子交換和肝素親和兩步層析,得純度為95%的重組蛋白,活性檢測顯示,重組蛋白具有與參照品一緻的促有絲分裂活性。
대원핵표체재체pET3c진행개건,소거재체상비필수적EcoRⅠ、HindⅢ한제매위점,연후재극륭위점BamHⅠ처인입LacZ편단,경차이보개건후적재체명명위pJN982。해재체보류료pET3c고효표체외원기인적능력,동시,기융합극륭위점유1개증지7개,병획득이목시법사선중조자적능력。응용해재체재E.coliBL21(DE3)pLysS중융합표체우감성성섬유세포생장인자,표체량점균체총단백30.04%。파쇄균체상청경양리자교환화간소친화량보층석,득순도위95%적중조단백,활성검측현시,중조단백구유여삼조품일치적촉유사분렬활성。
The prokaryote expression vector pET3c was modified by destroyingthe EcoRⅠ,HindⅢ restriction enzyme sites and inserting LacZ fragment in the BamH Ⅰ site .The derivative, named as pJN982,not only retained the ability of pET3 c to express exogenous gene efficiently but also had an increased number of fus ion cloning sites from 1 to 7,as well as gained the ability to identity the rec ombinant by visual screening of E.coli colonies .Using pJN982,fused bovine basic fibroblast growth factor(B-bFGF) was expressed in E.coli BL21(DE3)pLysS to a level of 30.04% of total celluar protein . The target protein was purified by cation exchange and heparin affinity chromatography from the supernant of bacteria lysate .It was found that the recombinant B-bFGF had an identical bio-activit y with the standard bFGF.